PRME Receives FDA RMAT Designation
Prime Medicine receives U.S. FDA Regenerative Medicine Advanced Therapy designation for PM359 to treat Chronic Granulomatous Disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.